FDA inspection
Boehringer Ingelheim Roxane Inc: FDA inspection ending Sep 17, 2008
FDA inspection 534935 · Voluntary Action Indicated (VAI) · Columbus, OH
Key facts
| Inspection ID | 534935 |
|---|---|
| Firm | Boehringer Ingelheim Roxane Inc |
| FEI number | 1527529 |
| Address | 330 Oak St |
| City | Columbus |
| State | OH |
| ZIP | 43215-4320 |
| Fiscal year | 2008 |
| Inspection end date | Sep 17, 2008 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data